A small trial of a new cancer drug has reportedly provided a result never before seen — the total remission of cancer in all of its participants.
According to a report in the New England Journal of Medicine, a dozen rectal cancer patients saw their tumors disappear completely after they received an experimental drug called dostarlimab.
“I believe this is the first time this has happened in the history of cancer,” Dr. Luis Alberto Diaz Jr., one of the trial leaders and a medical oncologist at Memorial Sloan Kettering (MSK) Cancer Center, told The New York Times.
Comments are closed.